The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization and predictors of long term (≥ 10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer patients.
 
Michael Friedlander
Honoraria - AstraZeneca; MSD
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - BeiGene (Inst)
 
John K. Chan
Honoraria - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology; Janssen Oncology; Mateon Therapeutics; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
 
Jim Java
Honoraria - Merck KGaA (I)
Consulting or Advisory Role - Merck KGaA (I)
 
Deborah K Armstrong
No Relationships to Disclose
 
Maurie Markman
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Amgen; Celgene; CritiTech; Myriad Genetics; Pfizer
Speakers' Bureau - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro
Expert Testimony - ACORN Research; Apotex; Dr. Reddy's Laboratories; Emcure; Fresenius Kabi; Hikma Pharmaceuticals; Hospira; Pharma International; Sagent; Strides Arcolab; Sun Pharma; Teva; Wockhardt Pharmaceuticals
 
Thomas J. Herzog
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Roche/Genentech; Tesaro
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Floor Jenniskens Backes
Consulting or Advisory Role - Tesaro; UpToDate
Research Funding - Clovis Oncology (Inst); Eisai (Inst); ImmunoGen (Inst)
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Pharmaceuticals; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Myriad Genetics; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Merck (Inst); Morphotek (Inst); PharmaMar (Inst); Prima BioMed (Inst); Tesaro (Inst)
 
Albert J. Bonebrake
No Relationships to Disclose
 
Peter Graham Rose
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Robert S. Mannel
Consulting or Advisory Role - Clovis Oncology (Inst); Tesaro (Inst)
 
Samuel S. Lentz
No Relationships to Disclose
 
Melissa Ann Geller
Speakers' Bureau - Tesaro
Research Funding - Bayer; FATE Therapeutics; Genentech; Morphotek; Ovagene Oncology; Tesaro
 
Larry J. Copeland
Consulting or Advisory Role - Clovis Oncology; Immunogen; Janssen Oncology; Tesaro; Tesaro
Expert Testimony - Johnson & Johnson